NeuBase Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

COMMON STOCK WARRANTS (Tables)

COMMON STOCK WARRANTS (Tables)

12 Months Ended

Sep. 30, 2015

Below is a table summarizing the warrants issued and outstanding as of September 30, 2015:

	Number Outstanding			Weighted-Average Exercise Price
Outstanding at September 30, 2012		8,527,638		$	2.80
Granted		56,667			4.32
Exercised		(2,396,774	)		2.78
Forfeited		(326,597	)		3.57
Outstanding at September 30, 2013		5,860,934		$	2.78
Granted		247,217			7.94
Exercised		(4,135,989	)		4.41
Forfeited		(25,154	)		1.20
Outstanding at September 30, 2014		1,947,008		$	3.64
Granted
Exercised		(1,015,638	)		3.03
Forfeited		(184,501	)		2.39
Outstanding at September 30, 2015		746,869		$	4.75
Exercisable at September 30, 2015		746,869		$	4.75

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details